NICOTINAMIDE-BASED KINASE INHIBITORS
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described. L'inventi...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
28.08.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.
L'invention concerne un composé de formule générale (I) ou des promédicaments, sels, hydrates, solvates, formes cristallines ou diastéréoisomères acceptables sur le plan pharmaceutique de celui-ci. L'invention concerne également un procédé de traitement d'états pathologiques associés à la tyrosine kinase chez un sujet au moyen dudit composé. |
---|---|
Bibliography: | Application Number: CA20032508171 |